Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Socpra Sciences Santé Et Humaines
Sherbrooke, Quebec, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Socpra Sciences Santé Et Humaines is a Canadian technology transfer and IP commercialization partnership associated with Université de Sherbrooke that holds and licenses university-origin IP, including mRNA biomarker portfolios and medical imaging technologies, to commercial entities such as Mainz Biomed for use in diagnostics including colorectal cancer screening tests. Clinical results and trial stages relate to partners’ products (e.g., ColoAlert), not to SOCPRA directly.
- Therapeutic areas
- Oncology
- Modalities
- mRNA-based drugsDevice
- Industry
- Consulting
02
Partnerships
Mainz Biomed
Beyond the preview
Go deeper on Socpra Sciences Santé Et Humaines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Socpra Sciences Santé Et Humaines.